Alivus Life Sciences P/B Ratio
Alivus Life Sciences P/B ratio. Alivus Life Sciences (ALIVUS) P/B ratio is 4.82 (High), book value per share ₹1332.80 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Analyse ALIVUS promoter holding to track promoter, FII and institutional holdings.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
ALIVUS P/B Ratio — Valuation Insights & Book Value Analysis
Alivus Life Sciences price-to-book ratio interpretation, valuation status and historical context — current P/B 4.82 (High). For live price, earnings yield and the full fundamental profile, see Alivus Life Sciences stock price NSE.
- Stock appears overvalued with PB of 4.82, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 490.7% above historical average
- Trading at premium to sector average PB of -0.01
Alivus Life Sciences P/B Ratio Historical Trend
ALIVUS annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Alivus Life Sciences 52-week for the annual high/low range and current price position.
ALIVUS Historical P/B Ratio — Book Value Per Share & Year-End Price
Alivus Life Sciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.94 | ₹1332.8 | ₹1250.60 | ₹3,332 | Low |
| 2025 | 0.81 | ₹1126.8 | ₹916.60 | ₹2,817 | Low |
| 2024 | 1.05 | ₹932.8 | ₹983.45 | ₹2,332 | Moderate |
| 2023 | 0.77 | ₹855.2 | ₹657.05 | ₹2,138 | Low |
| 2022 | 0.51 | ₹821.6 | ₹420.15 | ₹2,054 | Low |
ALIVUS vs Healthcare Peers — P/B Ratio Comparison
Alivus Life Sciences P/B 4.82 vs Healthcare average -0.01, median 0.6 — range -6.55–1.06.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.32 | ₹43 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.79 | ₹130 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.22 | ₹53 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |